These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10070319)

  • 1. CD44 exon v6 correlates with cellular differentiation but not with progression and metastasis of cervical cancer.
    Tokumo K; Kodama J; Seki N; Miyagi Y; Yoshinouchi M; Kudo T
    Eur J Cancer; 1998 Dec; 34(13):2107-11. PubMed ID: 10070319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD44 exon v6 is not implicated in the progression and metastasis of endometrial cancer.
    Tokumo K; Kodama J; Seki N; Miyagi Y; Yoshinouchi M; Kudo T
    Cancer Lett; 1998 Mar; 125(1-2):221-5. PubMed ID: 9566719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas.
    Berner HS; Suo Z; Risberg B; Villman K; Karlsson MG; Nesland JM
    Histopathology; 2003 Jun; 42(6):546-54. PubMed ID: 12786890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of CD44 standard and variant isoforms during the development and progression of uterine cervical tumours.
    Saegusa M; Hashimura M; Machida D; Okayasu I
    J Pathol; 1999 Jan; 187(2):173-83. PubMed ID: 10365092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E-cadherin, CD44 and CD44v6 in squamous intraepithelial lesions and invasive carcinomas of the uterine cervix: an immunohistochemical study.
    Faleiro-Rodrigues C; Lopes C
    Pathobiology; 2004; 71(6):329-36. PubMed ID: 15627844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splice variants of CD44 in human cervical cancer stage IB to IIB.
    Kainz C; Kohlberger P; Sliutz G; Tempfer C; Heinzl H; Reinthaller A; Breitenecker G; Koelbl H
    Gynecol Oncol; 1995 Jun; 57(3):383-7. PubMed ID: 7539775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression patterns of standard and variant CD44 molecules in normal uterine cervix and cervical cancer.
    Shimabukuro K; Toyama-Sorimachi N; Ozaki Y; Goi T; Furukawa K; Miyasaka M; Aso T
    Gynecol Oncol; 1997 Jan; 64(1):26-34. PubMed ID: 8995543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44 splicing pattern is associated with disease progression in pulmonary adenocarcinoma.
    Lee LN; Kuo SH; Lee YC; Chang YL; Chang HC; Jan IS; Yang PC
    J Formos Med Assoc; 2005 Aug; 104(8):541-8. PubMed ID: 16193174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 expression in cervical intraepithelial neoplasia (CIN) and carcinoma.
    Gorham H; Woodman A; Goodison S; Marsh J; Charnock M; Manek S; Sugino T; Tarin D
    Mol Diagn; 1999 Mar; 4(1):45-56. PubMed ID: 10229774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer.
    Liu YJ; Yan PS; Li J; Jia JF
    World J Gastroenterol; 2005 Nov; 11(42):6601-6. PubMed ID: 16425351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of CD44 variant exon 6 in invasion of head and neck squamous cell carcinoma.
    Kanke M; Fujii M; Kameyama K; Kanzaki J; Tokumaru Y; Imanishi Y; Tomita T; Matsumura Y
    Arch Otolaryngol Head Neck Surg; 2000 Oct; 126(10):1217-23. PubMed ID: 11031408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of CD44v6 expression with ovarian cancer progression and recurrence.
    Shi J; Zhou Z; Di W; Li N
    BMC Cancer; 2013 Apr; 13():182. PubMed ID: 23565736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of CD44v6 and RCAS1 in Uterine Cervical Carcinoma Infected with Human Papillomavirus and Its Effect on Cell Proliferation and Differentiation.
    Suwiwat S; Tungsinmunlong K; Siriaungkul S
    Asian Pac J Cancer Prev; 2022 Jul; 23(7):2431-2439. PubMed ID: 35901351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of CD44v6 mRNA significantly correlates with distant metastasis and poor prognosis in gastric cancer.
    Yamamichi K; Uehara Y; Kitamura N; Nakane Y; Hioki K
    Int J Cancer; 1998 Jun; 79(3):256-62. PubMed ID: 9645347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
    Nguyen VN; Mirejovský T; Melinová L; Mandys V
    Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44v3 and v6 variant isoform expression correlates with poor prognosis in early-stage vulvar cancer.
    Tempfer C; Sliutz G; Haeusler G; Speiser P; Reinthaller A; Breitenecker G; Vavra N; Kainz C
    Br J Cancer; 1998 Oct; 78(8):1091-4. PubMed ID: 9792156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of CD44 splicing variants in advanced colorectal carcinomas.
    Weg-Remers S; Anders M; von Lampe B; Riecken EO; Schüder G; Feifel G; Zeitz M; Stallmach A
    Eur J Cancer; 1998 Sep; 34(10):1607-11. PubMed ID: 9893637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44v6 is not relevant in colorectal tumour progression.
    Morrin M; Delaney PV
    Int J Colorectal Dis; 2002 Jan; 17(1):30-6. PubMed ID: 12018451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44 variant overexpression in gallbladder carcinoma associated with tumor dedifferentiation.
    Yanagisawa N; Mikami T; Mitomi H; Saegusa M; Koike M; Okayasu I
    Cancer; 2001 Jan; 91(2):408-16. PubMed ID: 11180088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CD44 variants and prognosis in oesophageal squamous cell carcinoma.
    Gotoda T; Matsumura Y; Kondo H; Ono H; Kanamoto A; Kato H; Watanabe H; Tachimori Y; Nakanishi Y; Kakizoe T
    Gut; 2000 Jan; 46(1):14-9. PubMed ID: 10601048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.